-
The BIR issued Revenue Memorandum Circular 62-2025, adding 10 more VAT-exempt medicines for cancer, diabetes, high cholesterol, hypertension, and mental illness, reducing healthcare costs for Filipino patients.
-
The VAT exemption aligns with RA 10963 (TRAIN Law) and RA 11534 (CREATE Act), reflecting a government push to improve access to essential medicines through updated tax relief measures.
-
Newly exempt medicines include tegafur-based oral chemotherapy, metformin-teneligliptin for diabetes, atorvastatin-fenofibrate for cholesterol, metoprolol-ivabradine for hypertension, and lamotrigine in various formulations for mental health treatment.
-
The BIR emphasized continued collaboration with the FDA and DOH, pledging further reviews to expand the VAT-free medicine list and enhance public health support through tax policy.
Sources:
Latest Posts in "Philippines"
- Philippines Proposes VAT Reduction to 10% to Combat Inflation and Boost Economy
- AstraZeneca Secures ₱37M VAT Refund from BIR for Exempted Medicine Imports
- Philippine Court Grants Partial VAT Refund to AstraZeneca Subsidiary for 2020 Drug Imports
- Philippines Launches VAT Portal for Non-Resident Digital Service Providers to Enhance Compliance
- Philippines Announces VAT Exemption on Medicines to Lower Healthcare Costs and Improve Access
